Daily non-political popular news in brief.

Who should receive vaccines and antiviral drugs in the event of a flu pandemic?

A new study in PLoS Medicine finds that 30 percent of nations have prioritized neither vaccine nor drugs in their pandemic influenza preparedness plans.

Read more »

Keywords: receive, vaccines, antiviral, drugs, event, flu, pandemic, vaccine, drug

« Previous | Next »

Similar news on "Who should receive vaccines and antiviral drugs in the event of a flu pandemic?":

1. Bypassing eggs, flu vaccine grown in insect cells shows promise
   04-10-2007 · EurekAlert!
   An experimental flu vaccine made in insect cells -- not in eggs, where flu vaccines currently available in the United States are grown -- is safe and as effective as conventional vaccines in protecting people against the flu. Removing eggs from the flu vaccine manufacturing process could allow a vaccine to be produced in large amounts much more quickly, a key advantage if a bird flu pandemic were to occur.
   Similar news · Read more »
   
2. Drug resistance in an influenza pandemic
   01-22-2007 · EurekAlert!
   Stockpiling large amounts of oseltamivir (Tamiflu) and related antiviral drugs with the intent to treat a large fraction of the population is a key part of pandemic preparedness of many countries. However, it is known that influenza viruses can develop resistance to these drugs. New research suggests that wide-spread use of antiviral drugs during a pandemic carries a substantial risk of resistance emerging and resistant influenza strains causing illness in a substantial number of people.
   Similar news · Read more »
   
3. New target for anti-flu drug development
   08-15-2007 · EurekAlert!
   Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Mass., in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-flu drugs, including those that may be effective against potentially pandemic influenza strains like H5N1. The findings have been published in the Aug. 15, 2007, issue of the journal Cell Cycle. A figure from their paper was selected for the journal cover.
   Similar news · Read more »
   
4. Bird flu -- Call for antiviral drugs to be shared
   01-22-2007 · EurekAlert!
   New predictions about bird flu, involving the use of a mathematical model, suggest that international cooperation to share antiviral drugs might be the best way to deal with an emerging pandemic.
   Similar news · Read more »
   
5. Combination of drugs should be stockpiled to fight flu pandemic, say experts
   02-08-2007 · EurekAlert!
   A combination of antiviral drugs should be stockpiled for use in an influenza pandemic, say researchers in this week's BMJ. We currently have two classes of drugs that are effective against influenza viruses: the ion channel inhibitors (amantadine and rimantadine) and the neuraminidase inhibitors (oseltamivir and zanamivir).
   Similar news · Read more »
   
6. Updates on pandemic flu vaccine trials to be presented at 44th annual IDSA meeting
   10-12-2006 · EurekAlert!
   Preliminary results from clinical trials testing two different pandemic flu vaccine approaches -- one a prime-boost strategy using different subtypes of H5N1 vaccines, the other an H5N1 vaccine delivered into the skin rather than the muscle -- will be presented at the 44th Annual Meeting of the Infectious Diseases Society of America being held in Toronto on Oct. 12-15. The presentations are scheduled for a late-breaker session on Friday afternoon, Oct. 13.
   Similar news · Read more »
   
7. MIT finds key to avian flu in humans
   01-06-2008 · Massachusetts Institute of Technology (MIT)
   MIT researchers have uncovered a critical difference between flu viruses that infect birds and humans, a discovery that could help scientists monitor the evolution of avian flu strains and aid in the development of vaccines against a deadly flu pandemic.
   Similar news · Read more »
   
8. Hepatitis B drug can compromise HIV treatment
   06-20-2007 · EurekAlert!
   Treating hepatitis B patients with the drug entecavir can cause those who are also infected with HIV to become resistant to two of the most important drugs in the anti-HIV arsenal. In findings published in the New England Journal of Medicine, researchers reported that a patient infected with both hepatitis B and HIV who was treated with entecavir developed a mutant strain of HIV that is resistant to the antiviral drugs lamivudine and emtricitabine.
   Similar news · Read more »
   
9. Mayo Clinic Proceedings Jan. tip sheet
   01-18-2008 · EurekAlert!
   Featured articles from the Jan. issue of Mayo Clinic Proceedings include the effects of antioxidant supplements on cancer, guidelines for workplace drug screening and the safety and effectiveness of nasal spray flu vaccine.
   Similar news · Read more »
   
10. Malaria product portfolio would benefit from greater cohesion amongst stakeholders
    10-03-2007 · EurekAlert!
    Malaria drug and vaccine research is booming. According to a report launched today in the UK byAustralian researchers at the George Institute for International Health, 16 new malaria vaccinecandidates are now in clinical trials; six new malaria drugs are about to reach the market; and by2011 we will have up to 12 new antimalarial drug product registered.
    Similar news · Read more »